arXiv · 2602.10570
Virtual Theranostic Trials: New Approach Methodologies (NAMs) and Precision Radiopharmaceutical Therapies
Abstract
Radiopharmaceutical therapies are expanding rapidly, but clinical evidence generation is limited by operational constraints and biological heterogeneity in radiopharmaceutical delivery and radiation risk. Virtual theranostic trials can run as companion trials, linking quantitative imaging to patient-specific models to generate evidence for personalized injections and scheduling, accelerate development, and broaden access.
Explore related subjects
Keep this discovery
Carlos F. Uribe, Hamid Abdollahi, Tahir Yusufaly, Taylor J. McColl, Maziar Sabouri, James Fowler, Fereshteh Yousefirizi, Babak Saboury, Pedro L. Esquinas, Arman Rahmim. 2026-02-11. Virtual Theranostic Trials: New Approach Methodologies (NAMs) and Precision Radiopharmaceutical Therapies. https://arxiv.org/abs/2602.10570
Cite the original work for its findings. Save a collection to share your selection of sources.